The increase of endothelial progenitor cells in the peripheral blood: A new parameter for detecting onset and severity of sepsis

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 3, 2008, Pages 697-705

  Becchi, C ^a   Pillozzi, S ^b   Fabbri, L P ^a   Al Malyan, M ^a   Caciapuoti, C ^a   Della Bella, C ^c   Nucera, M ^a   Masselli, M ^b   Boncinelli, S ^a   Arcangeli, A ^b   Amedei, Amedeo ^c,d  

^a Section of Anaesthesia and Intensive Care   (Italy)

^b Department of Experimental Pathology and Oncology ^*  (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

CD34* cells; CXCL8; Endothelial progenitor cells; Severe sepsis; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD LEVEL; CD34 SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD STEM CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROGNOSIS; SEPSIS;

EID: 53749095979     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100324     Document Type: Article

References (31)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348(16): 1546-54.
2. Ryan M, Levy MM. Clinical review: fever in intensive care unit patients. Crit Care 2003; 7(3): 221-5.
3. Henneke P, Golenbock DT. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 2002; 30(S):207-13.
4. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 1999; 274(12):7611-4.
5. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, Ondothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83(3):536-45
6. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994; 127(2):537-46.
7. Rüegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeunc FJ. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 1998; 4(4):408-14.
8. Dimmeler S, Hermann C, Galle J, Zeiher AM. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19(3):656-64.
9. Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F. Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol 2003; 522:83-97.
10. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348(7):593-600.
11. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization. by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18(14):3964-72.
12. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97(7):3422-7.
13. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001; 97(11):3354-60.
14. Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci 2001; 938:36-45.
15. Biancone L, Cantaluppi V, Duò D, Deregibus MC, Torre C, Camussi G. Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 2004; 173(8):5268-74.
16. Schömig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A, Schömig A, Ott I. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 2006; 27(9):1032-7.
17. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95(3):952-8.
18. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172(7):854-60.
19. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6.
20. World Medical Association. Ethical principles for medical research involving human subjects. Eur J Emerg Med 2001; 8:221-224.
21. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van Ackern K, Yard BA, Beck GCh. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 2007; 35(7): 1677-84.
22. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89(1):1-7.
23. Vasa M, Fichtlscherier S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103(24):2885-9.
24. Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24(7):1246-52.
25. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95(4):343-53.
26. van der Flier H.J, van Leeuwen KP, van Kessel JL, Kimpen AI, Hoepelman J, Geelen SP. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005; 23:35-38.
27. Pickkers P, Sprong T, Eijk L, Hoeven. H, Smits P, Deuren M. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005; 24:508-512.
28. Rau BM, Kemppainen EA, Gumbs AA, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 2007; 245:745-754.
29. Zuppa AA, Calabrese V, D'Andrea V, Fracchiolla A, Scorrano A, Orchi C, Romagnoli C. Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis Minerva Pediatr 2007; 59(3):267-74.
30. Ruud TE, Gundersen Y, Wang JE, Foster SJ, Thiemermann C, Aasen AO. Activation of cytokine synthesis by systemic infusions of lipopolysaccharide and peptidoglycan in a porcine model in vivo and in vitro. Surg Infect (Larchmt) 2007; 8(5):495-503.
31. Fox A, Smythe J, Fisher N, Tyler MP, McGrouther DA, Watt SM, Harris AL. Mobilization of endothelial progenitor cells into the circulation in burned patients. Br J Surg 2008; 95(2):244-251.